NRC Health (NRC) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of NRC Health and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 30, 2026. Differences are shown without an overall score or investment verdict.
NRC
NRC Health
$21.85HealthcareAt close: Aug 28, 2026, 4:00 PM ET
PDSB
PDS Biotechnology Corporation
$0.21HealthcareAt close: Aug 28, 2026, 4:00 PM ET
Total return — NRC vs PDSB
growth of $100 · dividends reinvested · last 10yNRC +64.2% (+5.1%/yr)PDSB -99.9% (-49.0%/yr)NRC compounded faster over this window
Log scale — wide-divergence pair
NRC PDSB
NRC vs PDSB: by the numbers
- •NRC is the larger company ($492M vs $12M market cap).
- •NRC is profitable (4.18% net margin) while PDSB runs a net loss (0.00%).
- •NRC pays a dividend (2.75% yield), while PDSB has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | NRC | PDSB |
|---|---|---|
| P/E ratio | 86.57 | N/A |
| Forward P/E | 24.83 | N/A |
| P/S ratio | 3.44 | N/A |
| P/B ratio | 73.43 | 3.45 |
| EV / EBITDA | 24.29 | 0.02 |
| FCF yield | 4.50% | N/A |
Profitability
| Metric | NRC | PDSB |
|---|---|---|
| Gross margin | 56.33% | 0.00% |
| Operating margin | 10.53% | 0.00% |
| Net margin | 4.18% | 0.00% |
| ROE | 89.43% | -372.85% |
| ROIC | 8.75% | -3699.99% |
Dividends
| Metric | NRC | PDSB |
|---|---|---|
| Dividend yield | 2.75% | N/A |
| Payout ratio | 115.38% | N/A |
Growth (annualized)
| Metric | NRC | PDSB |
|---|---|---|
| Revenue CAGR (5Y) | -0.02% | N/A |
| EPS CAGR (5Y) | -18.88% | N/A |
| FCF CAGR (5Y) | -14.35% | N/A |
| Total return CAGR (5Y) | -14.85% | -57.05% |
Frequently asked
- Does NRC or PDSB pay a bigger dividend?
- NRC pays a dividend (2.75% yield), while PDSB has no payments in the available dividend history.
- Is NRC or PDSB more profitable?
- NRC runs the higher net margin — NRC at 4.18% versus PDSB at 0.00%.
- How have NRC and PDSB total returns compared?
- Over the past 10 years, NRC delivered 4.82% and PDSB delivered -49.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
NRC Health P/E ratioNRC Health dividend yieldNRC Health ROEPDS Biotechnology ROENRC Health operating marginPDS Biotechnology operating marginNRC Health revenue growthPDS Biotechnology revenue growthNRC Health free cash flowPDS Biotechnology free cash flow
NRC Health & PDS Biotechnology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 30, 2026.